Skip to main content
VCbacked
Log inGet Started

Jobs at Post-IPO Equity companies that just raised

Updated August 20265 companies80 remote

There are 168 open roles at Post-IPO Equity companies that raised in the last 60 days, including 43 in engineering and 80 remote.

Every employer below closed a Post-IPO Equity round inside the last 60 days. A round that closed weeks ago means new budget and a headcount plan written against it, which is why every card below leads with the round, the amount and how long ago the money landed. These careers feeds do not publish salary, so no salary is shown or estimated.

Browse and filter the full boardGet an alert the moment a company raises

168 roles

Showing the 50 most recently posted. Use the board to see the rest.

Senior/Staff AI Scientist, Antibody Design

Absci · Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the the…

United States - Remote·today(remote)

View role
Post-IPO Equity · $100Mraised 58 days agoled by Eli Lilly, AMD101-250 employees
Senior/Staff AI Scientist, Target Discovery

Absci · Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the the…

United States - Remote·today(remote)

View role
Post-IPO Equity · $100Mraised 58 days agoled by Eli Lilly, AMD101-250 employees
Sr. MSL/MSL - Gulf

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·today(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Sr. Manager, AP

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

San Francisco - 1800 Owens·today

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Area Business Manager - Atrruby (West)

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·today(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Area Business Manager - Attruby (Central)

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·today(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
MSL - West

Definium Therapeutics · Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…

Remote·1 day ago(remote)

View role
Post-IPO Equity · $805Mraised 59 days agoled by Janus Henderson Investors, Great Point Partners
MSL - Mid West

Definium Therapeutics · Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…

Remote·1 day ago(remote)

View role
Post-IPO Equity · $805Mraised 59 days agoled by Janus Henderson Investors, Great Point Partners
MSL - East

Definium Therapeutics · Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…

Remote·1 day ago(remote)

View role
Post-IPO Equity · $805Mraised 59 days agoled by Janus Henderson Investors, Great Point Partners
Senior MSL - Mid West

Definium Therapeutics · Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…

Remote·1 day ago(remote)

View role
Post-IPO Equity · $805Mraised 59 days agoled by Janus Henderson Investors, Great Point Partners
Staff Engineer - Validation

Ambiq Micro · Ambiq Micro is a semiconductor manufacturing company that develops mixed-signal solutions for wireless electro…

Hsinchu City, Taiwan·1 day ago

View role
Post-IPO Equity · $179Mraised 59 days agoled by Kleiner Perkins, Cisco101-250 employees
Patient Access Liaison - New York City

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·1 day ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Patient Access Liaison - Rockies

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·1 day ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Patient Access Liaison - Great Plains

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·1 day ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Senior Manager Analytical Operations

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·1 day ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Senior MSL - West

Definium Therapeutics · Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…

Remote·2 days ago(remote)

View role
Post-IPO Equity · $805Mraised 59 days agoled by Janus Henderson Investors, Great Point Partners
Senior MSL - East

Definium Therapeutics · Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…

Remote·2 days ago(remote)

View role
Post-IPO Equity · $805Mraised 59 days agoled by Janus Henderson Investors, Great Point Partners
Area Business Manager - Attruby (East)

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Field Based - United States·2 days ago

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Area Business Manager - Attruby

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·2 days ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Field Development Director - Attruby

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Field Based - United States·2 days ago

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Director, Analytical Development

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·4 days ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Director of Physical Design

Ambiq Micro · Ambiq Micro is a semiconductor manufacturing company that develops mixed-signal solutions for wireless electro…

Austin, Texas, United States·4 days ago

View role
Post-IPO Equity · $179Mraised 59 days agoled by Kleiner Perkins, Cisco101-250 employees
Marketing Director Programs & Operations

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

San Francisco - 1800 Owens·6 days ago

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
General Counsel

Ambiq Micro · Ambiq Micro is a semiconductor manufacturing company that develops mixed-signal solutions for wireless electro…

Austin, Texas, United States·8 days ago

View role
Post-IPO Equity · $179Mraised 59 days agoled by Kleiner Perkins, Cisco101-250 employees
Principal Edge AI Firmware Engineer

Ambiq Micro · Ambiq Micro is a semiconductor manufacturing company that develops mixed-signal solutions for wireless electro…

Austin, Texas, United States·8 days ago

View role
Post-IPO Equity · $179Mraised 59 days agoled by Kleiner Perkins, Cisco101-250 employees
Director, Supply Chain - Commercial

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - Netherlands; Remote - United States·9 days ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Endocrine Account Manager - New Orleans

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·9 days ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Endocrine Account Manager - Indianapolis

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·9 days ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Associate Director, Portfolio Intelligence

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Palo Alto - 3160 Porter·9 days ago

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Director/Sr. Director Clinical Pharmacology

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

Remote - USA·9 days ago(remote)

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Director, Omnichannel Analytics

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

San Francisco - 1800 Owens·9 days ago

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
Senior Director, Clinical Development

BridgeBio · BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases…

San Francisco - 1800 Owens·9 days ago

View role
Post-IPO Equity · $1.0Braised 51 days agoled by Sequoia Capital, Sixth Street501-1000 employees
See all 168 roles on the board

This board is the last 60 days

The roles here come from 174 companies that closed a round in the last 60 days. VCBacked itself covers the funded universe well beyond that window: round size, stage and date, lead investors, industry and city for each company, plus founder and executive contact records, exportable to CSV.

Start Free TrialGet alerts when new rounds close

Related job pages

Counts are open roles inside the same 60-day funding window. Only cuts with at least 8 roles get a page.

By role

Engineering jobs43Sales jobs33Operations jobs15Data & AI jobs4Marketing jobs4Product jobs4

By city

Austin jobs25San Francisco jobs24Hsinchu City jobs9Palo Alto jobs8

Frequently Asked Questions

How many open roles are there at Post-IPO Equity companies that just raised?

There are 168 open roles at Post-IPO Equity companies that raised in the last 60 days, including 43 in engineering and 80 remote. They sit across 5 companies, and the page lists the 50 most recently posted of them.

What does "freshly funded" mean here?

Every employer on this page closed its most recent funding round within the last 60 days. That is a hard cap: a company drops off the board the day its round passes 60 days old, which is why the counts on this page move week to week.

Which companies on this page have the most open roles?

The employers with the most open roles on this page right now are BridgeBio (95), Ambiq Micro (45), Definium Therapeutics (22), Absci (3), LB Pharmaceuticals (3). Each of them raised inside the last 60 days.

Where are these roles based?

The locations with the most roles on this page are Austin (25), San Francisco (24), Hsinchu City (9), Palo Alto (8), and 80 of the roles are flagged remote by the employer. Locations are printed exactly as the employer publishes them on its own careers feed.

Is salary shown?

No. The applicant tracking system feeds behind these roles do not publish salary bands, so no salary figure or estimate appears anywhere on this board. Each card shows the round, the amount raised, how long ago it closed, the lead investors and the team size instead.

How current is this page?

It rebuilds from the database several times a day. The most recent round represented on the wider board closed on 2026-07-30, and the board currently carries 3,076 roles at 174 companies in total.

Go past the 60-day window

The 174 companies hiring above are the ones that raised this quarter. VCBacked has the funding history behind them and the rest of the funded universe with it — amounts, dates, stages, lead investors, and founder and executive contacts you can export.

Start Free Trial